“A 3T MR Imaging Investigation of the Topography of Whole Spinal Cord Atrophy in Multiple Sclerosis.” Klein JP, Arora A, Neema M, Healy BC, Tauhid S, Goldberg-Zimring D, Chavarro-Nieto C, Stankiewicz JM, Cohen AB, Buckle GJ, Houtchens MK, Ceccarelli A, Dell’oglio E, Guttmann CR, Alsop DC, Hackney DB, Bakshi R. AJNR Am J Neuroradiol, 32:1138-1142 (2011).
“Phase III Dose-Comparison Study of Glatiramer Acetate for Multiple Sclerosis.” Comi G, Cohen JA, Arnold DL, Wynn D, Filippi M, for the FORTE Study Group. Annals of Neurology, 69:75-82 (2011).
“Brain MRI Lesion Load at 1.5T and 3T vs. Clinical Status in Multiple Sclerosis.” Stankiewicz JM, Glanz BI, Healy BC, Arora A, Neema M, Benedict RHB, Guss ZD, Tauhid S, Buckle GJ, Houtchens MK, Khoury S, Weiner HL, Guttmann CRG, Bakshi R. J Neuroimaging. 21 e50 (2011).
“A Multicenter Assessment of Cervical Cord Atrophy Among MS Clinical Phenotyes.” Rocca MA, Horsfield MA, Sala S, Copetti M, Valsasina P, Mesaros S, Rodegher ME, Caputo D, Stosic-Opincal T, Drulovic J, Comi G, Filippi M. Neurology, 76:2096-2102 (2011).